CVS Health Corporation (CVS)

Market Cap	71.52B
Revenue (ttm)	367.25B
Net Income (ttm)	5.02B
Shares Out	1.26B
EPS (ttm)	3.95
PE Ratio	14.37
Forward PE	9.47
Dividend	$2.66 (4.68%)
Ex-Dividend Date	Oct 21, 2024

Volume	11,424,045
Open	56.25
Previous Close	55.77
Day's Range	56.00 - 57.67
52-Week Range	52.71 - 83.25
Beta	0.54
Analysts	Buy
Price Target	73.00 (+28.45%)
Earnings Date	Nov 6, 2024

About CVS

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers phar...

• Industry: Healthcare Plans
• Sector: Healthcare
• Founded: 1963
• Employees: 300,000
• Stock Exchange: NYSE
• Ticker Symbol: CVS
• Website: https://www.cvshealth.com

Financial Performance

In 2023, CVS Health's revenue was $356.62 billion, an increase of 10.88% compared to the previous year's $321.63 billion. Earnings were $8.34 billion, an increase of 93.55%.

Analyst Forecast

According to 17 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $73.0, which is an increase of 28.45% from the latest price.

Price Target

$73.0

(28.45% upside)

Analyst Consensus: Buy